摘要
BACKGROUND There is growing evidence that patients with coronavirus disease 2019(COVID-19)frequently present with liver impairment.Hepatitis B virus(HBV)remains a major public health threat in current society.Both severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and HBV can cause liver damage,and current findings on whether HBV infection increases disease severity in COVID-19 patients are inconsistent,and whether SARS-CoV-2 infection accelerates hepatitis B progression or leads to a worse prognosis in hepatitis B patients has not been adequately elucidated.AIM To explore the complex relationship between COVID-19 and hepatitis B in order to inform the research and management of patients co-infected with SARS-CoV-2 and HBV.METHODS An experienced information specialist searched the literature in the following online databases:PubMed,China National Knowledge Infrastructure,Google Scholar,Scopus,Wiley,Web of Science,Cochrane,and ScienceDirect.The literature published from December 2019 to September 1,2022 was included in the search.We also searched medRxiv and bioRxiv for gray literature and manually scanned references of included articles.Articles reporting studies conducted in humans discussing hepatitis B and COVID-19 were included.We excluded duplicate publications.News reports,reports,and other gray literature were included if they contained quantifiable evidence(case reports,findings,and qualitative analysis).Some topics that included HBV or COVID-19 samples but did not have quantitative evidence were excluded from the review.RESULTS A total of 57 studies were eligible and included in this review.They were from 11 countries,of which 33(57.9%)were from China.Forty-two of the 57 studies reported abnormalities in liver enzymes,three mainly reported abnormalities in blood parameters,four indicated no significant liver function alterations,and another eight studies did not provide data on changes in liver function.Fifty-seven studies were retrospective and the total number of co-infections was 1932,the largest sample size was 7723,and the largest number of co-infections was 353.Most of the studies suggested an interaction between hepatitis B and COVID-19,while 12 studies clearly indicated no interaction between hepatitis B and COVID-19.Six of the 57 studies clearly reported HBV activation.Six studies were related to liver transplant patients.CONCLUSION There is some association between COVID-19 and hepatitis B.Future high-quality randomized trials are needed to further elucidate the interaction between COVID-19 and hepatitis B.
